1. Real-world data for regulatory decision making: challenges and possible solutions for Europe;Cave;Clin. Pharmacol. Ther.,2019
2. The United States Food and Drug Administration, Submitting documents using real-world data and real-world evidence to FDA for drugs and biologics guidance for industry, 2019. 〈https://www.fda.gov/regulatory-information/search-fda-guidance-documents/submitting-documents-using-real-world-data-and-real-world-evidence-fda-drugs-and-biologics-guidance〉. (Accessed 22 June 2021).
3. The United States Food and Drug Administration, Framework for FDA’s real-world evidence program, 2018. 〈https://www.fda.gov/media/120060/download〉. (Accessed 22 June 2021).
4. Data rich, information poor: can we use electronic health records to create a learning healthcare system for pharmaceuticals;Eichler;Clin. Pharmacol. Ther.,2019
5. International Diabetes Federation, IDF diabetes atlas, ninth ed., 2019. 〈https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf〉. (Accessed 22 June 2021).